18,525,000 Shares of Common Stock 4,840 Shares of Series B Convertible Preferred Stock Warrants to Purchase 5,841,250 Shares of Common Stock DYNAVAX TECHNOLOGIES CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • August 8th, 2019 • Dynavax Technologies Corp • Pharmaceutical preparations • New York
